- Home
- IMNM vs EXPI Comparison
IMNM vs EXPI Comparison
Compare IMNM & EXPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMNM | EXPI |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMNM | EXPI |
|---|---|---|
| Price | $24.04 | $8.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $31.22 | $12.00 |
| AVG Volume (30 Days) | ★ 2.1M | 866.5K |
| Earning Date | 03-18-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $9,679,000.00 | ★ $4,678,653,000.00 |
| Revenue This Year | N/A | $6.03 |
| Revenue Next Year | $11.53 | $5.37 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.12 |
| 52 Week Low | $5.15 | $6.90 |
| 52 Week High | $27.65 | $12.23 |
Technical Indicators
Market Signals| Indicator | IMNM | EXPI |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 28.28 |
| Support Level | $23.86 | $8.28 |
| Resistance Level | $27.65 | $9.14 |
| Average True Range (ATR) | 1.63 | 0.29 |
| MACD | -0.08 | -0.05 |
| Stochastic Oscillator | 62.94 | 8.87 |
Price Performance
Historical ComparisonAbout IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.